Company Name: Syros Pharmaceuticals, Inc. 

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development of gene control medicines using its proprietary gene control platform. The company’s areas of focus include cancer and immune-mediated diseases.

Ticker Symbol: SYRS (NASDAQ)

Company Website:

Social Media:

Syros Pharmaceuticals LinkedIn

Syros Pharmaceuticals Twitter

Headquarters: Cambridge, Massachusetts